References
- Andreoli V. It medico e la droga. Masson, Milan 1979; 95–121
- Browner W. S., . Estimating sample size and power. Designing Clinical Research, S. R. Huliey, S. R. Cunnings, et al. Williams & Wilkins, Baltimore 1988; 139
- Cushmann P. Abstinence following detoxification and methadone maintenance treatment. JAMA 1978; 65: 46–52
- Gold M. S., et al. Clonidtne blocks acute withdrawal symptoms. Lancet 1978; 1: 929
- Jaffe J. H. Drug addiction and drug abuse. The Pharmacological Basis of Therapeutics7th ed., G. A. Goodman, L. S. Goodman, T. W. Rail, F. Murad. Macmillan, New York 1985; 532
- Jaffe J. H., Martin W. R. Opioid analgesic and antagonists. The Pharmacological Basis of Therapeutics.7th ed., G. A. Goodman, L. S. Goodman, T. W. Rail, F. Murad. Macmillan, New York 1985; 491–531
- Lowenstein J. Clonidine. Ann. Intern. Med. 1980; 92: 74–77
- Malizia A., Andreucci G. Le tossicodipcndenze. Fed. Med. 1988; 41(1)29–36
- Newman R. G. Methadone treatment: Defining and evaluating success. N. Engl. J. Med. 1987; 317: 447–450
- Silsby H., Tennant F. S., JR. Short-term ambulatory detoxification of opiate addicts using methadone. Int. J. Addict. 1974; 9: 167–170
- Stimmel B., Goldberg J., Rotkopf E., Cohen M. Ability to remain abstinent after methadone detoxification. A six-year study. JAMA 1977; 237: 1216–1220